HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fertility drugs and cutaneous melanoma risk: a French prospective cohort study.

Abstract
Cutaneous melanoma has been suspected to be influenced by female sex hormones. A review of the literature in 2018 indicated that fertility drug (FD) use was associated with increased melanoma risk among parous women only. However, most studies so far were based on a retrospective design and the current evidence is unclear. We sought to prospectively investigate the associations between FD use and melanoma risk in women. E3N is a prospective cohort of 98 995 French women aged 40-65 years at inclusion in 1990. Information on use of FDs, including duration and time of administration, was assessed through self-administered questionnaires. We used Cox proportional hazards regression models adjusted for age and melanoma risk factors. Over 1990-2008, about 611 melanoma cases were ascertained among 86 653 women. Compared with never use, ever use of FDs was not associated with melanoma risk overall [hazard ratio (HR) = 1.15; 95% confidence interval (CI) = 0.75-1.74], or among parous women (HR = 1.08; 95% CI = 0.67-1.73). Among ever users of FDs, duration of use and age at first use were not associated with melanoma risk. Associations were similar after adjustment for UV exposure, although FD users were more likely to report tanning bed use than never-users (odds ratio = 1.50; CI = 1.01-2.22) in a subsample with recreational UV exposure data. Our data do not support an association between FD use and melanoma risk, but underlie the importance of taking into consideration potential confounding from sun exposure in future research.
AuthorsIris Cervenka, Marie Al Rahmoun, Yahya Mahamat-Saleh, Marie-Christine Boutron-Ruault, Agnès Fournier, Marina Kvaskoff
JournalEuropean journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) (Eur J Cancer Prev) Vol. 29 Issue 2 Pg. 182-185 (03 2020) ISSN: 1473-5709 [Electronic] England
PMID31764213 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Fertility Agents
Topics
  • Adult
  • Age Factors
  • Aged
  • Aged, 80 and over
  • Confounding Factors, Epidemiologic
  • Drug Administration Schedule
  • Female
  • Fertility Agents (administration & dosage, adverse effects)
  • Follow-Up Studies
  • France (epidemiology)
  • Humans
  • Melanoma (epidemiology, etiology, pathology)
  • Middle Aged
  • Proportional Hazards Models
  • Prospective Studies
  • Risk Factors
  • Skin (drug effects, pathology, radiation effects)
  • Skin Neoplasms (epidemiology, etiology, pathology)
  • Sunbathing (statistics & numerical data)
  • Time Factors
  • Ultraviolet Rays (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: